Search clinical trials for: Empaglifozin placebo Linagliptin placebo
Total 53855 results
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
EMSNot yet recruitingType 2 Diabetes Mellitus
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Japan
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Austria, Germany
-
University Hospital, Gentofte, CopenhagenEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
University Medical Centre LjubljanaUnknownDiabetes Complications | Diabetes Mellitus, Type 1 | Vascular Stiffness | Hypoglycemic AgentsSlovenia
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
EMSNot yet recruiting
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
The University of Hong KongResearch Grant CouncilRecruitingCirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 InhibitorsHong Kong
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Doris...RecruitingType2 Diabetes | Heart Failure With Preserved Ejection FractionUnited States
-
The University of Texas Health Science Center at...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
University of PennsylvaniaRecruitingHeart Failure With Preserved Ejection FractionUnited States
-
Anita SarafThe Pittsburgh FoundationNot yet recruitingHeart Failure | Adult Congenital Heart DiseaseUnited States
-
Sadat City UniversityBeni-Suef UniversityCompleted
-
University Hospital, Gentofte, CopenhagenCompletedDiabetes After Total PancreatectomyDenmark
-
The Deutsche Diabetes Forschungsgesellschaft e.V.Novo Nordisk A/S; Boehringer Ingelheim; Federal Ministry of Health, Germany; German... and other collaboratorsRecruitingType 2 Diabetes | Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)Germany, Austria
-
Instituto Nacional de Cardiologia Ignacio ChavezNot yet recruitingSTEMI | No-Reflow Phenomenon
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, Germany, India, Ireland, Japan, Switzerland
-
Northwell HealthWithdrawnDiabetes | SGLT-2 Inhibitors | Advanced Glycation End Products
-
Emory UniversityMerck Sharp & Dohme LLCTerminated
-
Brigham and Women's HospitalPatient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...Active, not recruitingType2 Diabetes | Renal Disease | Cardiovascular EventsUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.CompletedType 2 Diabetes MellitusChina
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Bangladesh, Belgium, Canada, China, Germany, Guatemala, Hong Kong, India, Lebanon, Mexico, Peru, Philippines, Spain, Taiwan
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedHypertension | Diabetes Mellitus, Type 2United States
-
Boehringer IngelheimCompletedKidney Disease, ChronicUnited States, Spain, Korea, Republic of, Belgium, Australia, Hong Kong, India, Canada, China, Germany, Italy, Japan, Malaysia, Finland, Switzerland, Turkey, Hungary, Poland, Portugal, Philippines, Czechia, Greece, Bulgaria, Brazil, Arg... and more
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
-
Yale UniversityBoehringer IngelheimRecruitingEnd Stage Renal Disease on DialysisUnited States
-
The University of Hong KongFood and Health Bureau, Hong KongCompletedNon-alcoholic Fatty Liver DiseaseHong Kong
-
Alexandria UniversityRecruiting
-
University of PisaUnknownType 2 Diabetes | Urinary Tract InfectionsItaly
-
University Hospital Inselspital, BerneFresenius KabiCompletedMalnourishment | Gastrointestinal TumorsSwitzerland
-
Miulli General HospitalNot yet recruitingHeart Failure | Obesity | Diabetes Mellitus | Atrial FibrillationItaly
-
Boehringer IngelheimEli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2
-
Merck Sharp & Dohme LLCCompleted
-
Medanta, The Medicity, IndiaNot yet recruitingEmpagliflozin Versus Linagliptin in Renal Ransplant Recipients With Diabetes Mellitus (EmLina Renal)Diabetes Mellitus | Kidney Transplant; Complications
-
Saint Luke's Health SystemCompletedHeart FailureUnited States
-
University of Erlangen-Nürnberg Medical SchoolCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Japan
-
Alexandria UniversityRecruitingPolycystic Ovary Syndrome (PCOS)Egypt
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Universidad de GuanajuatoHospital Regional de Alta Especialidad del BajioUnknownInsulin Resistance | Prediabetic StateMexico
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, France, Germany, Greece, India, Ireland, Japan, Korea, Republic of, Mexico, Philippines, Slovakia, Slovenia, Switzerland, Taiwan, Turkey, Ukraine